Rhumbline Advisers Tenaya Therapeutics, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 79,599 shares of TNYA stock, worth $116,214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,599
Previous 78,160
1.84%
Holding current value
$116,214
Previous $242,000
36.78%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$13.7 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$10.2 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$9.83 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$5.95 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$4.69 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $60.4M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...